| Name |
Operil 0,5 mg/ml kapi za nos, otopina za odrasle |
| Marketing Authorisation Number |
HR-H-702745651 |
| Active Substance |
oksimetazolinklorid |
| Composition |
1 ml kapi za nos otopine sadrži 0,5 mg oksimetazolinklorida, što odgovara 0,44 mg oksimetazolina |
| Pharmaceutical Form |
kapi za nos, otopina |
| Manufacturer |
Laboratori Fundacio Dau, Barcelona, Španjolska |
| Marketing Authorisation Holder |
Phoenix Labs Unlimited Company, Suite 12, Bunkilla Plaza, Bracetown Business Park, Clonee, County Meath, Irska |
| Marketing Authorisation Date |
19.12.2022 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/17-02/754 |
| Registration Number |
381-12-01/70-22-20 |
| Prescription |
Medicinal product not subject to medical prescription |
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
allowed |
| ATC Code |
R01AA05 |
| Marketing status |
stavljeno u promet |
| Shortage status |
nema nestašice |
| SmPC |
download |
| PL |
download |
